Studying a new insulin sensitizer for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 1 diabetes for at least one year.
- You are between 18 and 45 years old.
- Your latest A1c is below 10%.
- You have a BMI between 18 and 35, and either a BMI of 25 or higher or use at least 0.5 units of insulin per kilogram of body weight each day.
- You currently use a closed-loop automated insulin delivery system that works with a Dexcom G7 continuous glucose monitor.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests an investigational pill (called cadisegliatin) added to your usual insulin treatment for people with type 1 diabetes who use an automated insulin pump. It aims to improve blood sugar control and reduce the time your sugar is too high.
This trial tests a drug that may help your body use insulin better and improve how your cells produce energy. It might lead to better blood sugar control and less insulin needed.
This study is testing a new wearable sensor that tracks both glucose (sugar) and ketone levels continuously. It might help people with type 1 diabetes manage their condition better and avoid complications.
This study tests an artificial intelligence feature that helps the insulin pump deliver extra insulin before meals. It aims to improve blood sugar control for adults with type 1 diabetes who already use an automated insulin delivery system.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
Hear when a new Glycemic Control for Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.